Genmab Geared Up To Launch Epkinly With AbbVie

As FDA Approves CD20xCD3 Bispecific For Lymphoma

 
• By Kevin Grogan
  
Epkinly edges ahead of glofitamab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip